| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Leiomyoma | 49 | 2024 | 644 | 7.660 |
Why?
|
| Uterine Neoplasms | 52 | 2024 | 1424 | 5.780 |
Why?
|
| Chromosome Aberrations | 53 | 2024 | 1776 | 5.250 |
Why?
|
| Translocation, Genetic | 60 | 2024 | 1392 | 4.700 |
Why?
|
| Deafness | 26 | 2025 | 460 | 3.190 |
Why?
|
| Gene Rearrangement | 19 | 2021 | 1142 | 2.830 |
Why?
|
| Chromosome Disorders | 16 | 2021 | 498 | 2.690 |
Why?
|
| Hearing Loss | 21 | 2025 | 785 | 2.530 |
Why?
|
| Karyotyping | 69 | 2019 | 1176 | 2.150 |
Why?
|
| Chromosome Mapping | 103 | 2024 | 4618 | 2.020 |
Why?
|
| Leiomyomatosis | 8 | 2016 | 69 | 1.960 |
Why?
|
| Hearing Loss, Sensorineural | 23 | 2019 | 783 | 1.890 |
Why?
|
| Chromosomal Position Effects | 3 | 2018 | 12 | 1.790 |
Why?
|
| In Situ Hybridization, Fluorescence | 71 | 2017 | 2511 | 1.760 |
Why?
|
| Chromosomes, Human | 6 | 2020 | 437 | 1.750 |
Why?
|
| Cochlea | 25 | 2022 | 848 | 1.750 |
Why?
|
| HMGA2 Protein | 11 | 2012 | 101 | 1.720 |
Why?
|
| Genetics, Medical | 7 | 2021 | 334 | 1.660 |
Why?
|
| Genome, Human | 19 | 2024 | 4443 | 1.650 |
Why?
|
| Chromosome Breakpoints | 6 | 2020 | 93 | 1.640 |
Why?
|
| Cytogenetic Analysis | 15 | 2021 | 270 | 1.530 |
Why?
|
| Oligospermia | 2 | 2023 | 61 | 1.530 |
Why?
|
| Chromosomes, Human, Pair 5 | 13 | 2016 | 386 | 1.410 |
Why?
|
| Neonatal Screening | 8 | 2025 | 619 | 1.390 |
Why?
|
| Chromosomes, Human, Pair 12 | 16 | 2012 | 432 | 1.360 |
Why?
|
| Abnormalities, Multiple | 10 | 2020 | 1424 | 1.330 |
Why?
|
| Prenatal Diagnosis | 9 | 2020 | 1271 | 1.280 |
Why?
|
| Vestibular Diseases | 8 | 2014 | 232 | 1.270 |
Why?
|
| Extracellular Matrix Proteins | 26 | 2019 | 833 | 1.260 |
Why?
|
| Congenital Abnormalities | 6 | 2019 | 703 | 1.250 |
Why?
|
| Chromosome Deletion | 21 | 2021 | 1384 | 1.210 |
Why?
|
| Chromosomes, Human, Pair 7 | 18 | 2010 | 310 | 1.160 |
Why?
|
| Hearing | 8 | 2021 | 504 | 1.110 |
Why?
|
| Nucleotides | 2 | 2020 | 454 | 1.040 |
Why?
|
| Chromosome Inversion | 9 | 2017 | 119 | 1.040 |
Why?
|
| Proteins | 27 | 2024 | 6002 | 1.030 |
Why?
|
| Phenotype | 34 | 2024 | 16721 | 1.010 |
Why?
|
| Abortion, Habitual | 2 | 2023 | 65 | 1.000 |
Why?
|
| Genetic Predisposition to Disease | 33 | 2024 | 18075 | 0.950 |
Why?
|
| High Mobility Group Proteins | 8 | 2002 | 179 | 0.880 |
Why?
|
| Chromosomes, Human, Pair 2 | 12 | 2012 | 313 | 0.860 |
Why?
|
| Myometrium | 6 | 2012 | 174 | 0.840 |
Why?
|
| Genetic Testing | 12 | 2025 | 3590 | 0.800 |
Why?
|
| Genome-Wide Association Study | 15 | 2024 | 12807 | 0.800 |
Why?
|
| Chromosomes, Human, Pair 1 | 14 | 2016 | 640 | 0.800 |
Why?
|
| Developmental Disabilities | 6 | 2018 | 1519 | 0.790 |
Why?
|
| Chromosomes, Human, Pair 14 | 13 | 2005 | 285 | 0.770 |
Why?
|
| Smooth Muscle Tumor | 2 | 2016 | 65 | 0.710 |
Why?
|
| Infertility, Male | 2 | 2022 | 395 | 0.700 |
Why?
|
| Chromosome Banding | 28 | 2016 | 261 | 0.680 |
Why?
|
| Chromosomes, Human, Pair 9 | 9 | 2008 | 533 | 0.680 |
Why?
|
| Frameshift Mutation | 4 | 2019 | 392 | 0.680 |
Why?
|
| Tooth Abnormalities | 1 | 2020 | 56 | 0.680 |
Why?
|
| Genes, Dominant | 5 | 2020 | 855 | 0.670 |
Why?
|
| Genetic Linkage | 26 | 2012 | 2342 | 0.670 |
Why?
|
| Facies | 2 | 2020 | 224 | 0.660 |
Why?
|
| Hearing Tests | 5 | 2025 | 123 | 0.660 |
Why?
|
| Trisomy | 11 | 2004 | 260 | 0.660 |
Why?
|
| Leiomyosarcoma | 6 | 2008 | 426 | 0.650 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 10 | 2019 | 3795 | 0.650 |
Why?
|
| Base Sequence | 69 | 2021 | 12412 | 0.640 |
Why?
|
| Bone Diseases, Developmental | 2 | 2020 | 131 | 0.640 |
Why?
|
| Genes | 24 | 2002 | 1824 | 0.640 |
Why?
|
| Serine Proteases | 1 | 2018 | 44 | 0.620 |
Why?
|
| Genomics | 12 | 2025 | 5924 | 0.620 |
Why?
|
| Lipoma | 6 | 2004 | 294 | 0.610 |
Why?
|
| Humans | 344 | 2025 | 766432 | 0.600 |
Why?
|
| Polymerase Chain Reaction | 18 | 2020 | 6061 | 0.590 |
Why?
|
| Mediator Complex | 1 | 2018 | 106 | 0.570 |
Why?
|
| Molecular Sequence Data | 79 | 2014 | 17605 | 0.570 |
Why?
|
| Chromosome Breakage | 8 | 2012 | 159 | 0.550 |
Why?
|
| Speech | 1 | 2021 | 555 | 0.530 |
Why?
|
| DNA-Binding Proteins | 16 | 2019 | 9611 | 0.530 |
Why?
|
| Expressed Sequence Tags | 7 | 2007 | 251 | 0.530 |
Why?
|
| Gene Expression Profiling | 13 | 2018 | 9521 | 0.520 |
Why?
|
| Ear, Inner | 9 | 2016 | 426 | 0.510 |
Why?
|
| Hearing Disorders | 5 | 2019 | 126 | 0.510 |
Why?
|
| Vascular Neoplasms | 2 | 2016 | 167 | 0.500 |
Why?
|
| Alleles | 11 | 2017 | 6894 | 0.490 |
Why?
|
| Hysterectomy | 5 | 2023 | 863 | 0.490 |
Why?
|
| High-Throughput Nucleotide Sequencing | 7 | 2024 | 3664 | 0.490 |
Why?
|
| Gene Library | 8 | 2017 | 1065 | 0.480 |
Why?
|
| Societies, Scientific | 2 | 2015 | 221 | 0.480 |
Why?
|
| X Chromosome | 7 | 2013 | 819 | 0.470 |
Why?
|
| Mutation | 45 | 2021 | 30220 | 0.470 |
Why?
|
| Haploinsufficiency | 3 | 2013 | 334 | 0.470 |
Why?
|
| Female | 166 | 2024 | 396354 | 0.460 |
Why?
|
| Mosaicism | 6 | 2009 | 481 | 0.440 |
Why?
|
| Sequence Analysis, DNA | 26 | 2024 | 4779 | 0.440 |
Why?
|
| Pedigree | 28 | 2021 | 4537 | 0.430 |
Why?
|
| Chromosome Painting | 3 | 2001 | 26 | 0.430 |
Why?
|
| Genomic Library | 2 | 2012 | 189 | 0.420 |
Why?
|
| CHARGE Syndrome | 1 | 2012 | 34 | 0.410 |
Why?
|
| Comparative Genomic Hybridization | 6 | 2023 | 474 | 0.410 |
Why?
|
| Receptors, Estrogen | 3 | 2022 | 2251 | 0.410 |
Why?
|
| Chromosomes, Human, Pair 8 | 8 | 2020 | 451 | 0.410 |
Why?
|
| Uterine Artery Embolization | 2 | 2023 | 62 | 0.400 |
Why?
|
| Gene Expression Regulation, Neoplastic | 11 | 2017 | 8619 | 0.400 |
Why?
|
| Genetic Heterogeneity | 3 | 2012 | 735 | 0.390 |
Why?
|
| Ear, Middle | 1 | 2014 | 341 | 0.390 |
Why?
|
| Chromosomes, Human, Pair 6 | 9 | 2001 | 370 | 0.370 |
Why?
|
| Endometriosis | 1 | 2019 | 868 | 0.370 |
Why?
|
| Hearing Loss, Bilateral | 2 | 2009 | 53 | 0.360 |
Why?
|
| Gene Deletion | 8 | 2011 | 2668 | 0.360 |
Why?
|
| Nucleic Acid Hybridization | 31 | 2004 | 1305 | 0.360 |
Why?
|
| RNA, Messenger | 31 | 2024 | 12788 | 0.360 |
Why?
|
| Siblings | 3 | 2012 | 828 | 0.350 |
Why?
|
| Amino Acid Sequence | 46 | 2017 | 13410 | 0.350 |
Why?
|
| DNA Primers | 11 | 2020 | 2824 | 0.350 |
Why?
|
| Gene Expression Regulation, Developmental | 11 | 2011 | 3607 | 0.350 |
Why?
|
| Cleft Palate | 7 | 2016 | 596 | 0.340 |
Why?
|
| Vestibule, Labyrinth | 2 | 2010 | 235 | 0.340 |
Why?
|
| DNA, Complementary | 18 | 2007 | 1988 | 0.340 |
Why?
|
| Fetus | 10 | 2006 | 1878 | 0.340 |
Why?
|
| Histone Demethylases | 1 | 2013 | 328 | 0.340 |
Why?
|
| Congresses as Topic | 1 | 2015 | 811 | 0.340 |
Why?
|
| Publishing | 2 | 2015 | 837 | 0.330 |
Why?
|
| COUP Transcription Factor I | 1 | 2009 | 12 | 0.330 |
Why?
|
| Sequence Deletion | 3 | 2013 | 1494 | 0.330 |
Why?
|
| Mutation, Missense | 8 | 2014 | 2590 | 0.330 |
Why?
|
| Oncogene Proteins, Fusion | 3 | 2008 | 1609 | 0.330 |
Why?
|
| Chromosomes, Human, Pair 11 | 8 | 2014 | 412 | 0.330 |
Why?
|
| Cytogenetics | 4 | 2016 | 197 | 0.320 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 15 | 2011 | 4566 | 0.320 |
Why?
|
| Fetal Growth Retardation | 3 | 2006 | 591 | 0.320 |
Why?
|
| Peritoneal Neoplasms | 2 | 2010 | 706 | 0.320 |
Why?
|
| Blotting, Northern | 11 | 2006 | 1549 | 0.310 |
Why?
|
| Software | 3 | 2022 | 4464 | 0.310 |
Why?
|
| Chromosomes, Human, Pair 20 | 4 | 2017 | 127 | 0.310 |
Why?
|
| Cell Cycle Proteins | 2 | 2019 | 3439 | 0.300 |
Why?
|
| Computational Biology | 5 | 2022 | 3564 | 0.300 |
Why?
|
| Physical Chromosome Mapping | 4 | 2002 | 183 | 0.300 |
Why?
|
| Mice | 74 | 2024 | 81863 | 0.300 |
Why?
|
| Gene Expression | 20 | 2019 | 7583 | 0.300 |
Why?
|
| Fumarate Hydratase | 2 | 2007 | 55 | 0.300 |
Why?
|
| Immunohistochemistry | 14 | 2012 | 11059 | 0.300 |
Why?
|
| Kallmann Syndrome | 3 | 2023 | 142 | 0.290 |
Why?
|
| Animals | 104 | 2024 | 168887 | 0.290 |
Why?
|
| Infant, Newborn | 19 | 2025 | 26388 | 0.290 |
Why?
|
| Transcription, Genetic | 15 | 2012 | 7607 | 0.290 |
Why?
|
| Purine-Nucleoside Phosphorylase | 1 | 2007 | 28 | 0.290 |
Why?
|
| Chromosomes, Human, Pair 3 | 6 | 2007 | 322 | 0.280 |
Why?
|
| Diacylglycerol Kinase | 1 | 2007 | 47 | 0.280 |
Why?
|
| Chromosomes, Human, Pair 10 | 8 | 2007 | 275 | 0.280 |
Why?
|
| Human Development | 1 | 2008 | 122 | 0.270 |
Why?
|
| Adult | 70 | 2024 | 223253 | 0.270 |
Why?
|
| Chromosomes, Human, 6-12 and X | 8 | 2000 | 69 | 0.270 |
Why?
|
| In Situ Hybridization | 13 | 2011 | 1887 | 0.270 |
Why?
|
| Chromosomes, Human, Pair 17 | 9 | 2004 | 418 | 0.270 |
Why?
|
| Terminology as Topic | 1 | 2014 | 1539 | 0.270 |
Why?
|
| Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2008 | 230 | 0.270 |
Why?
|
| Chromosomes, Human, Pair 22 | 3 | 2023 | 348 | 0.270 |
Why?
|
| Photosensitivity Disorders | 1 | 2006 | 79 | 0.270 |
Why?
|
| Collagen Type IX | 1 | 2006 | 20 | 0.270 |
Why?
|
| Keratosis | 1 | 2006 | 81 | 0.270 |
Why?
|
| Research Design | 2 | 2021 | 6205 | 0.260 |
Why?
|
| Male | 113 | 2024 | 363975 | 0.260 |
Why?
|
| Genetic Variation | 7 | 2021 | 6612 | 0.260 |
Why?
|
| Chromosomes, Human, Pair 21 | 3 | 2005 | 228 | 0.260 |
Why?
|
| Steroid 17-alpha-Hydroxylase | 1 | 2006 | 100 | 0.260 |
Why?
|
| Decidua | 1 | 2006 | 80 | 0.260 |
Why?
|
| Postural Balance | 1 | 2010 | 637 | 0.260 |
Why?
|
| Chromatin | 1 | 2018 | 2979 | 0.250 |
Why?
|
| Gene Frequency | 5 | 2021 | 3624 | 0.250 |
Why?
|
| DNA | 29 | 2020 | 7207 | 0.250 |
Why?
|
| Multigene Family | 10 | 2016 | 1081 | 0.250 |
Why?
|
| Introns | 9 | 2004 | 965 | 0.250 |
Why?
|
| Gene Amplification | 6 | 2002 | 1088 | 0.250 |
Why?
|
| GTP-Binding Proteins | 4 | 1998 | 946 | 0.250 |
Why?
|
| Leadership | 1 | 2015 | 1394 | 0.250 |
Why?
|
| Janus Kinase 2 | 1 | 2008 | 562 | 0.240 |
Why?
|
| Response Elements | 2 | 2020 | 308 | 0.240 |
Why?
|
| Cochlear Diseases | 2 | 2020 | 23 | 0.240 |
Why?
|
| Ring Chromosomes | 1 | 2024 | 26 | 0.240 |
Why?
|
| Fetal Proteins | 2 | 1995 | 100 | 0.240 |
Why?
|
| Syndrome | 16 | 2016 | 3271 | 0.240 |
Why?
|
| Trophoblasts | 1 | 2006 | 223 | 0.230 |
Why?
|
| Nose | 2 | 2019 | 522 | 0.230 |
Why?
|
| Polymorphism, Single Nucleotide | 11 | 2024 | 16042 | 0.230 |
Why?
|
| DNA Mutational Analysis | 14 | 2018 | 4114 | 0.230 |
Why?
|
| 3' Untranslated Regions | 1 | 2006 | 514 | 0.220 |
Why?
|
| Germ-Line Mutation | 4 | 2024 | 1885 | 0.220 |
Why?
|
| Ear | 2 | 2006 | 172 | 0.220 |
Why?
|
| Periodicals as Topic | 1 | 2015 | 1463 | 0.220 |
Why?
|
| Chromosomes | 5 | 2019 | 578 | 0.220 |
Why?
|
| Collagen | 4 | 2004 | 2634 | 0.220 |
Why?
|
| Collagen Type II | 2 | 2014 | 151 | 0.220 |
Why?
|
| Maxillofacial Abnormalities | 2 | 2014 | 22 | 0.210 |
Why?
|
| Myosins | 3 | 2021 | 407 | 0.210 |
Why?
|
| Cloning, Molecular | 29 | 2001 | 4167 | 0.210 |
Why?
|
| Transcription Factors | 11 | 2013 | 12147 | 0.210 |
Why?
|
| Uterus | 2 | 2009 | 660 | 0.210 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2010 | 1363 | 0.210 |
Why?
|
| Hybrid Cells | 19 | 1998 | 421 | 0.210 |
Why?
|
| Craniofacial Abnormalities | 3 | 2012 | 320 | 0.210 |
Why?
|
| Homeodomain Proteins | 3 | 2010 | 2430 | 0.210 |
Why?
|
| Craniofacial Dysostosis | 2 | 2014 | 74 | 0.210 |
Why?
|
| Azoospermia | 1 | 2022 | 28 | 0.210 |
Why?
|
| Glycoproteins | 5 | 2008 | 2201 | 0.200 |
Why?
|
| Pregnancy | 24 | 2024 | 30235 | 0.200 |
Why?
|
| Microarray Analysis | 3 | 2021 | 751 | 0.200 |
Why?
|
| Chromosomes, Human, X | 3 | 2014 | 319 | 0.200 |
Why?
|
| Genetic Markers | 8 | 2016 | 2603 | 0.200 |
Why?
|
| Chromosomes, Human, Pair 15 | 3 | 1999 | 361 | 0.190 |
Why?
|
| Integrases | 1 | 2024 | 520 | 0.190 |
Why?
|
| Nerve Tissue Proteins | 5 | 2018 | 4400 | 0.190 |
Why?
|
| Conserved Sequence | 5 | 2000 | 1159 | 0.190 |
Why?
|
| Cryosurgery | 1 | 2006 | 472 | 0.190 |
Why?
|
| Sequence Homology, Amino Acid | 17 | 2012 | 2746 | 0.190 |
Why?
|
| Cell Line | 21 | 2016 | 15563 | 0.190 |
Why?
|
| Sequence Alignment | 7 | 2014 | 2176 | 0.190 |
Why?
|
| Telomere | 2 | 2024 | 941 | 0.190 |
Why?
|
| Uniparental Disomy | 1 | 2021 | 46 | 0.180 |
Why?
|
| Mendelian Randomization Analysis | 3 | 2024 | 1044 | 0.180 |
Why?
|
| Dosage Compensation, Genetic | 3 | 2002 | 209 | 0.180 |
Why?
|
| Growth Differentiation Factor 6 | 1 | 2020 | 8 | 0.180 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 2020 | 205 | 0.180 |
Why?
|
| Cluster Analysis | 4 | 2012 | 2718 | 0.180 |
Why?
|
| Carrier Proteins | 9 | 2024 | 4924 | 0.180 |
Why?
|
| Evoked Potentials, Auditory, Brain Stem | 4 | 2010 | 256 | 0.180 |
Why?
|
| Testis | 4 | 2022 | 784 | 0.180 |
Why?
|
| Vesicular Transport Proteins | 1 | 2023 | 376 | 0.180 |
Why?
|
| Eye Abnormalities | 2 | 2014 | 243 | 0.180 |
Why?
|
| Genome | 4 | 2024 | 1751 | 0.180 |
Why?
|
| Oncogenes | 9 | 2003 | 1231 | 0.180 |
Why?
|
| Neoplasm Proteins | 8 | 2017 | 3601 | 0.170 |
Why?
|
| Photochemotherapy | 1 | 2006 | 828 | 0.170 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 4 | 1 | 2019 | 17 | 0.170 |
Why?
|
| Exons | 17 | 2013 | 2392 | 0.170 |
Why?
|
| DNA, Neoplasm | 10 | 2003 | 1741 | 0.170 |
Why?
|
| Gene Expression Regulation | 11 | 2018 | 11919 | 0.170 |
Why?
|
| Auditory Pathways | 1 | 2002 | 241 | 0.170 |
Why?
|
| Cerebellar Neoplasms | 1 | 2004 | 588 | 0.170 |
Why?
|
| Transducin | 2 | 1996 | 42 | 0.170 |
Why?
|
| Disease Models, Animal | 10 | 2019 | 18322 | 0.160 |
Why?
|
| Streptococcal Vaccines | 1 | 2019 | 46 | 0.160 |
Why?
|
| Menorrhagia | 1 | 2019 | 59 | 0.160 |
Why?
|
| Chromosomes, Human, Pair 16 | 4 | 1998 | 340 | 0.160 |
Why?
|
| Fertility | 1 | 2024 | 770 | 0.160 |
Why?
|
| Cell Adhesion Molecules | 3 | 2017 | 1612 | 0.160 |
Why?
|
| Nuclear Proteins | 3 | 2013 | 5794 | 0.160 |
Why?
|
| Hair Cells, Auditory | 3 | 2016 | 382 | 0.160 |
Why?
|
| Tumor Cells, Cultured | 14 | 2003 | 6105 | 0.160 |
Why?
|
| Middle Aged | 43 | 2024 | 223127 | 0.150 |
Why?
|
| Phosphoproteins | 4 | 2014 | 2446 | 0.150 |
Why?
|
| Workflow | 2 | 2022 | 859 | 0.150 |
Why?
|
| Cerebral Ventricles | 1 | 2001 | 550 | 0.150 |
Why?
|
| Genetic Counseling | 3 | 2016 | 634 | 0.150 |
Why?
|
| Ear Canal | 1 | 2019 | 149 | 0.150 |
Why?
|
| Seizures | 2 | 2013 | 2996 | 0.150 |
Why?
|
| Molecular Epidemiology | 1 | 2000 | 472 | 0.150 |
Why?
|
| Genotype | 13 | 2014 | 13034 | 0.150 |
Why?
|
| Tectorial Membrane | 1 | 1998 | 25 | 0.150 |
Why?
|
| Temporal Bone | 3 | 2016 | 683 | 0.150 |
Why?
|
| Gene Knock-In Techniques | 2 | 2010 | 419 | 0.150 |
Why?
|
| Heart Defects, Congenital | 4 | 2012 | 4712 | 0.150 |
Why?
|
| Heterozygote | 5 | 2018 | 2795 | 0.150 |
Why?
|
| Human Genome Project | 5 | 2017 | 202 | 0.150 |
Why?
|
| Family Health | 5 | 2010 | 1253 | 0.150 |
Why?
|
| Chromosomes, Human, Pair 13 | 4 | 2004 | 192 | 0.140 |
Why?
|
| Muscle, Smooth, Vascular | 2 | 2002 | 1494 | 0.140 |
Why?
|
| Pseudogenes | 4 | 2003 | 104 | 0.140 |
Why?
|
| Myxoma | 3 | 2004 | 114 | 0.140 |
Why?
|
| Retinitis Pigmentosa | 4 | 2004 | 395 | 0.140 |
Why?
|
| Exostoses, Multiple Hereditary | 2 | 2014 | 29 | 0.140 |
Why?
|
| Platelet Glycoprotein GPIb-IX Complex | 1 | 2018 | 144 | 0.140 |
Why?
|
| DNA Copy Number Variations | 5 | 2023 | 2043 | 0.140 |
Why?
|
| Zebrafish | 8 | 2024 | 3035 | 0.140 |
Why?
|
| Cadherins | 2 | 2018 | 901 | 0.140 |
Why?
|
| Choanal Atresia | 1 | 2017 | 41 | 0.140 |
Why?
|
| Child Development Disorders, Pervasive | 2 | 2012 | 597 | 0.140 |
Why?
|
| Self Disclosure | 1 | 2018 | 249 | 0.140 |
Why?
|
| Molecular Biology | 1 | 2000 | 573 | 0.140 |
Why?
|
| Skin Neoplasms | 2 | 2015 | 5860 | 0.140 |
Why?
|
| Sulfates | 1 | 1997 | 380 | 0.130 |
Why?
|
| Microphthalmos | 1 | 2017 | 58 | 0.130 |
Why?
|
| Waldenstrom Macroglobulinemia | 1 | 2005 | 1076 | 0.130 |
Why?
|
| CapZ Actin Capping Protein | 1 | 2016 | 11 | 0.130 |
Why?
|
| Dipeptidyl-Peptidases and Tripeptidyl-Peptidases | 1 | 2016 | 88 | 0.130 |
Why?
|
| Germ Cells | 2 | 2018 | 646 | 0.130 |
Why?
|
| Child, Preschool | 22 | 2021 | 42576 | 0.130 |
Why?
|
| Receptor Tyrosine Kinase-like Orphan Receptors | 1 | 2016 | 43 | 0.130 |
Why?
|
| Lod Score | 4 | 2012 | 600 | 0.130 |
Why?
|
| Heterochromatin | 2 | 2013 | 294 | 0.130 |
Why?
|
| Prostatic Neoplasms | 1 | 2018 | 11094 | 0.130 |
Why?
|
| SOX9 Transcription Factor | 1 | 2016 | 146 | 0.130 |
Why?
|
| Genetic Diseases, X-Linked | 2 | 2014 | 386 | 0.130 |
Why?
|
| Menopause | 1 | 2024 | 1657 | 0.130 |
Why?
|
| Synovitis, Pigmented Villonodular | 2 | 1992 | 32 | 0.120 |
Why?
|
| Muscle Hypotonia | 2 | 2016 | 166 | 0.120 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2003 | 1963 | 0.120 |
Why?
|
| Myosin Heavy Chains | 3 | 2004 | 403 | 0.120 |
Why?
|
| Phospholipase D | 1 | 1995 | 71 | 0.120 |
Why?
|
| Mice, Transgenic | 3 | 2024 | 9539 | 0.120 |
Why?
|
| RNA, Neoplasm | 4 | 2008 | 746 | 0.120 |
Why?
|
| Microfilament Proteins | 3 | 2005 | 1129 | 0.120 |
Why?
|
| Embryo, Mammalian | 5 | 2010 | 1675 | 0.120 |
Why?
|
| Auditory Threshold | 4 | 2010 | 369 | 0.120 |
Why?
|
| Membrane Transport Proteins | 2 | 2017 | 1029 | 0.120 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2011 | 3635 | 0.120 |
Why?
|
| Cytoskeletal Proteins | 4 | 2013 | 1324 | 0.120 |
Why?
|
| Nuclear Matrix-Associated Proteins | 1 | 2015 | 38 | 0.120 |
Why?
|
| Spiral Ganglion | 1 | 2016 | 180 | 0.120 |
Why?
|
| Mice, Knockout | 6 | 2018 | 14466 | 0.120 |
Why?
|
| Euchromatin | 2 | 2013 | 54 | 0.120 |
Why?
|
| Pneumococcal Infections | 1 | 2019 | 529 | 0.120 |
Why?
|
| Symporters | 2 | 2012 | 362 | 0.120 |
Why?
|
| Cochlear Duct | 2 | 2008 | 21 | 0.120 |
Why?
|
| Telomerase | 1 | 2019 | 750 | 0.120 |
Why?
|
| Muscular Dystrophies | 1 | 2017 | 393 | 0.110 |
Why?
|
| DNA Probes | 4 | 2006 | 541 | 0.110 |
Why?
|
| Haplotypes | 3 | 2017 | 2727 | 0.110 |
Why?
|
| Loss of Heterozygosity | 3 | 2006 | 663 | 0.110 |
Why?
|
| Child | 26 | 2021 | 80668 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 4 | 4 | 2000 | 378 | 0.110 |
Why?
|
| Zanthoxylum | 1 | 2013 | 1 | 0.110 |
Why?
|
| Mice, Inbred CBA | 3 | 2010 | 439 | 0.110 |
Why?
|
| POU Domain Factors | 1 | 2014 | 47 | 0.110 |
Why?
|
| Ataxia Telangiectasia | 5 | 1996 | 107 | 0.110 |
Why?
|
| Heart Neoplasms | 3 | 2004 | 374 | 0.110 |
Why?
|
| Streptococcus pneumoniae | 1 | 2019 | 764 | 0.110 |
Why?
|
| Blindness | 2 | 2002 | 585 | 0.110 |
Why?
|
| Aneuploidy | 5 | 2006 | 573 | 0.110 |
Why?
|
| Peripheral Vascular Diseases | 1 | 1997 | 488 | 0.110 |
Why?
|
| Potassium Channels | 1 | 2016 | 534 | 0.110 |
Why?
|
| Receptor, Cannabinoid, CB2 | 1 | 2013 | 48 | 0.110 |
Why?
|
| Biological Specimen Banks | 1 | 2019 | 788 | 0.110 |
Why?
|
| Morphogenesis | 2 | 2016 | 743 | 0.110 |
Why?
|
| Ultrasonography, Prenatal | 3 | 2012 | 1772 | 0.110 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2017 | 572 | 0.110 |
Why?
|
| Vascular Diseases | 1 | 2002 | 1161 | 0.110 |
Why?
|
| Neural Crest | 1 | 2016 | 277 | 0.110 |
Why?
|
| Facial Bones | 1 | 2014 | 209 | 0.110 |
Why?
|
| Sequence Homology, Nucleic Acid | 8 | 1997 | 1056 | 0.110 |
Why?
|
| Mice, Inbred C57BL | 13 | 2019 | 22337 | 0.110 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 7 | 2005 | 325 | 0.110 |
Why?
|
| Branchial Region | 1 | 2013 | 36 | 0.110 |
Why?
|
| Osteogenesis Imperfecta | 1 | 1993 | 81 | 0.110 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 2015 | 216 | 0.100 |
Why?
|
| Linkage Disequilibrium | 3 | 2019 | 1996 | 0.100 |
Why?
|
| Hearing Loss, Conductive | 1 | 2014 | 159 | 0.100 |
Why?
|
| Histone Deacetylases | 2 | 2012 | 712 | 0.100 |
Why?
|
| Receptor, Cannabinoid, CB1 | 1 | 2013 | 137 | 0.100 |
Why?
|
| Monocarboxylic Acid Transporters | 1 | 2012 | 81 | 0.100 |
Why?
|
| Genetics, Population | 2 | 2019 | 943 | 0.100 |
Why?
|
| 5' Untranslated Regions | 2 | 2016 | 255 | 0.100 |
Why?
|
| Aortic Coarctation | 1 | 2015 | 278 | 0.100 |
Why?
|
| Nucleolus Organizer Region | 2 | 1983 | 25 | 0.100 |
Why?
|
| Angiotensin II | 1 | 1995 | 844 | 0.100 |
Why?
|
| Genetic Diseases, Inborn | 3 | 2006 | 606 | 0.100 |
Why?
|
| Psychomotor Disorders | 1 | 2013 | 149 | 0.100 |
Why?
|
| SOXD Transcription Factors | 1 | 2012 | 44 | 0.100 |
Why?
|
| Alternative Splicing | 5 | 2012 | 1103 | 0.100 |
Why?
|
| Gene Transfer Techniques | 2 | 2024 | 1206 | 0.100 |
Why?
|
| Adaptor Proteins, Signal Transducing | 3 | 2007 | 2900 | 0.100 |
Why?
|
| Glaucoma | 3 | 2007 | 1194 | 0.100 |
Why?
|
| Connexins | 3 | 2017 | 355 | 0.100 |
Why?
|
| Pigmentation Disorders | 2 | 2004 | 105 | 0.100 |
Why?
|
| Guidelines as Topic | 3 | 2016 | 1394 | 0.100 |
Why?
|
| Chromosomes, Human, 4-5 | 3 | 1986 | 26 | 0.100 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2001 | 1559 | 0.100 |
Why?
|
| Leukemia, Myeloid | 3 | 2005 | 695 | 0.100 |
Why?
|
| Genes, Recessive | 9 | 2021 | 625 | 0.100 |
Why?
|
| Eye Proteins | 3 | 2004 | 628 | 0.100 |
Why?
|
| HLA Antigens | 4 | 1986 | 1339 | 0.090 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2017 | 723 | 0.090 |
Why?
|
| Gene Knockdown Techniques | 2 | 2013 | 1602 | 0.090 |
Why?
|
| Cell Transformation, Neoplastic | 3 | 2018 | 2839 | 0.090 |
Why?
|
| Twins | 3 | 1981 | 341 | 0.090 |
Why?
|
| Head | 2 | 2016 | 926 | 0.090 |
Why?
|
| Twins, Monozygotic | 3 | 1983 | 471 | 0.090 |
Why?
|
| Amides | 1 | 2013 | 451 | 0.090 |
Why?
|
| Tyrosine | 1 | 1995 | 1425 | 0.090 |
Why?
|
| Acidosis, Renal Tubular | 2 | 2002 | 50 | 0.090 |
Why?
|
| Adolescent | 19 | 2021 | 88898 | 0.090 |
Why?
|
| Immunoglobulin J Recombination Signal Sequence-Binding Protein | 1 | 2011 | 133 | 0.090 |
Why?
|
| Tissue Distribution | 6 | 2001 | 2275 | 0.090 |
Why?
|
| Genes, myc | 3 | 2002 | 391 | 0.090 |
Why?
|
| Proton-Translocating ATPases | 2 | 2002 | 112 | 0.090 |
Why?
|
| Peritoneal Cavity | 1 | 2010 | 135 | 0.090 |
Why?
|
| Epstein-Barr Virus Nuclear Antigens | 1 | 2011 | 158 | 0.090 |
Why?
|
| Language Development Disorders | 1 | 2012 | 194 | 0.090 |
Why?
|
| Genes, Lethal | 2 | 2007 | 224 | 0.090 |
Why?
|
| Plasmids | 3 | 2024 | 2267 | 0.090 |
Why?
|
| Polymorphism, Genetic | 7 | 1997 | 4249 | 0.090 |
Why?
|
| Calcium-Binding Proteins | 2 | 2002 | 1077 | 0.090 |
Why?
|
| Forkhead Transcription Factors | 1 | 2018 | 1625 | 0.090 |
Why?
|
| Cleft Lip | 2 | 2006 | 512 | 0.090 |
Why?
|
| Vestibular Function Tests | 2 | 2008 | 128 | 0.090 |
Why?
|
| Ion Channels | 3 | 2007 | 1043 | 0.090 |
Why?
|
| Blotting, Western | 5 | 2007 | 5021 | 0.090 |
Why?
|
| Placenta | 3 | 1995 | 1725 | 0.090 |
Why?
|
| Genes, Neoplasm | 2 | 2004 | 369 | 0.090 |
Why?
|
| Skull | 1 | 2014 | 819 | 0.080 |
Why?
|
| Trans-Activators | 4 | 2011 | 2854 | 0.080 |
Why?
|
| Vestibular Evoked Myogenic Potentials | 1 | 2010 | 88 | 0.080 |
Why?
|
| Protein Isoforms | 4 | 2013 | 1715 | 0.080 |
Why?
|
| Zebrafish Proteins | 2 | 2013 | 1017 | 0.080 |
Why?
|
| Polymorphism, Restriction Fragment Length | 10 | 1995 | 765 | 0.080 |
Why?
|
| Psychotria | 1 | 2009 | 1 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 19 | 3 | 2000 | 350 | 0.080 |
Why?
|
| Maternal Age | 3 | 2006 | 804 | 0.080 |
Why?
|
| Dinucleotide Repeats | 1 | 2009 | 28 | 0.080 |
Why?
|
| Antigens, Surface | 3 | 1988 | 1617 | 0.080 |
Why?
|
| Facial Asymmetry | 1 | 1990 | 173 | 0.080 |
Why?
|
| Contractile Proteins | 1 | 1990 | 240 | 0.080 |
Why?
|
| Hamartoma | 1 | 1991 | 235 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-myc | 2 | 2011 | 997 | 0.080 |
Why?
|
| Lymphocytes | 6 | 2012 | 2605 | 0.080 |
Why?
|
| Microcephaly | 1 | 2013 | 427 | 0.080 |
Why?
|
| Leiomyoma, Epithelioid | 1 | 2008 | 3 | 0.080 |
Why?
|
| Protein Structure, Tertiary | 4 | 2012 | 3757 | 0.080 |
Why?
|
| Transgenes | 2 | 2024 | 1014 | 0.080 |
Why?
|
| Disulfides | 2 | 2012 | 462 | 0.080 |
Why?
|
| Culture Techniques | 2 | 2003 | 529 | 0.080 |
Why?
|
| Haploidy | 2 | 2007 | 128 | 0.080 |
Why?
|
| Leukemia, Erythroblastic, Acute | 2 | 1985 | 176 | 0.070 |
Why?
|
| Receptors, Cell Surface | 2 | 2016 | 2815 | 0.070 |
Why?
|
| Infant | 16 | 2021 | 36460 | 0.070 |
Why?
|
| Body Dysmorphic Disorders | 1 | 2012 | 242 | 0.070 |
Why?
|
| Major Histocompatibility Complex | 3 | 1987 | 880 | 0.070 |
Why?
|
| Globins | 3 | 1993 | 405 | 0.070 |
Why?
|
| Glycosylation | 3 | 2014 | 1100 | 0.070 |
Why?
|
| Trabecular Meshwork | 2 | 2007 | 101 | 0.070 |
Why?
|
| Autistic Disorder | 4 | 2016 | 1238 | 0.070 |
Why?
|
| Membrane Proteins | 7 | 2023 | 7866 | 0.070 |
Why?
|
| Amniotic Fluid | 3 | 2001 | 381 | 0.070 |
Why?
|
| Acoustic Stimulation | 2 | 2010 | 1253 | 0.070 |
Why?
|
| Receptors, Antigen, T-Cell | 5 | 1990 | 2570 | 0.070 |
Why?
|
| Mice, Inbred Strains | 3 | 2007 | 1767 | 0.070 |
Why?
|
| Monosomy | 3 | 2001 | 52 | 0.070 |
Why?
|
| Gene Duplication | 3 | 2013 | 315 | 0.070 |
Why?
|
| Chromosomes, Human, 1-3 | 2 | 1984 | 21 | 0.070 |
Why?
|
| Mutagenesis, Insertional | 2 | 2024 | 663 | 0.070 |
Why?
|
| Microsatellite Repeats | 5 | 2005 | 784 | 0.070 |
Why?
|
| Pelvic Neoplasms | 1 | 1989 | 249 | 0.070 |
Why?
|
| Research | 2 | 2009 | 1977 | 0.070 |
Why?
|
| Limb Deformities, Congenital | 3 | 2003 | 136 | 0.070 |
Why?
|
| Gingival Hyperplasia | 1 | 2007 | 19 | 0.070 |
Why?
|
| Ocular Physiological Phenomena | 1 | 2007 | 67 | 0.070 |
Why?
|
| Protein Sorting Signals | 2 | 2000 | 274 | 0.070 |
Why?
|
| Sequence Tagged Sites | 3 | 2002 | 96 | 0.070 |
Why?
|
| Fetal Diseases | 1 | 2012 | 915 | 0.070 |
Why?
|
| Point Mutation | 5 | 2019 | 1591 | 0.070 |
Why?
|
| NFI Transcription Factors | 1 | 2007 | 49 | 0.070 |
Why?
|
| Genetic Association Studies | 1 | 2016 | 2746 | 0.070 |
Why?
|
| Heart Valve Diseases | 1 | 2015 | 1029 | 0.070 |
Why?
|
| Hypertrichosis | 1 | 2007 | 31 | 0.070 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2019 | 4410 | 0.070 |
Why?
|
| Protein Tyrosine Phosphatases | 3 | 2006 | 457 | 0.070 |
Why?
|
| Age Factors | 4 | 2015 | 18395 | 0.070 |
Why?
|
| Chondrosarcoma | 1 | 1989 | 305 | 0.070 |
Why?
|
| Gestational Age | 3 | 2006 | 3617 | 0.070 |
Why?
|
| SUMO-1 Protein | 1 | 2006 | 35 | 0.070 |
Why?
|
| RNA 3' Polyadenylation Signals | 1 | 2006 | 9 | 0.070 |
Why?
|
| Urogenital Abnormalities | 2 | 2007 | 255 | 0.070 |
Why?
|
| Scalp Dermatoses | 1 | 2006 | 44 | 0.070 |
Why?
|
| Small Ubiquitin-Related Modifier Proteins | 1 | 2006 | 68 | 0.070 |
Why?
|
| Access to Information | 1 | 2009 | 317 | 0.070 |
Why?
|
| Aged | 19 | 2019 | 171234 | 0.070 |
Why?
|
| Chromosomes, Human, 13-15 | 2 | 1985 | 49 | 0.060 |
Why?
|
| Facial Dermatoses | 1 | 2006 | 87 | 0.060 |
Why?
|
| RNA-Binding Proteins | 1 | 2015 | 1885 | 0.060 |
Why?
|
| Chromosomes, Human, Y | 1 | 2007 | 163 | 0.060 |
Why?
|
| Restriction Mapping | 6 | 1991 | 848 | 0.060 |
Why?
|
| Aminolevulinic Acid | 1 | 2006 | 147 | 0.060 |
Why?
|
| Stria Vascularis | 2 | 2022 | 30 | 0.060 |
Why?
|
| Herpesvirus 4, Human | 1 | 2011 | 1079 | 0.060 |
Why?
|
| Acyltransferases | 1 | 2007 | 305 | 0.060 |
Why?
|
| Insulin-Like Growth Factor II | 2 | 1990 | 271 | 0.060 |
Why?
|
| Somatomedins | 1 | 1986 | 179 | 0.060 |
Why?
|
| Interphase | 1 | 2005 | 226 | 0.060 |
Why?
|
| Breast Neoplasms | 5 | 2022 | 21157 | 0.060 |
Why?
|
| Phylogeny | 4 | 2009 | 2839 | 0.060 |
Why?
|
| Signal Transduction | 6 | 2019 | 23611 | 0.060 |
Why?
|
| Aging | 3 | 2015 | 8725 | 0.060 |
Why?
|
| Risk Factors | 5 | 2024 | 74828 | 0.060 |
Why?
|
| Nervous System Malformations | 1 | 2007 | 243 | 0.060 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2010 | 746 | 0.060 |
Why?
|
| Cataract | 1 | 2011 | 837 | 0.060 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2007 | 1168 | 0.060 |
Why?
|
| Boston | 1 | 2018 | 9333 | 0.060 |
Why?
|
| Epidermal Growth Factor | 2 | 1998 | 697 | 0.060 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2011 | 616 | 0.060 |
Why?
|
| Proportional Hazards Models | 1 | 2019 | 12527 | 0.060 |
Why?
|
| Aortic Valve | 1 | 2015 | 1964 | 0.060 |
Why?
|
| Esthetics | 1 | 2006 | 328 | 0.060 |
Why?
|
| Brain Neoplasms | 2 | 2004 | 9101 | 0.060 |
Why?
|
| Infarction | 1 | 2006 | 247 | 0.060 |
Why?
|
| United States | 6 | 2024 | 72910 | 0.060 |
Why?
|
| Trismus | 1 | 2004 | 33 | 0.060 |
Why?
|
| Preimplantation Diagnosis | 1 | 2006 | 143 | 0.060 |
Why?
|
| Aspartate Aminotransferases | 1 | 2006 | 416 | 0.060 |
Why?
|
| Clone Cells | 5 | 2002 | 1670 | 0.060 |
Why?
|
| Ecosystem | 1 | 2009 | 489 | 0.060 |
Why?
|
| Evolution, Molecular | 1 | 2013 | 1891 | 0.060 |
Why?
|
| DNA, Mitochondrial | 2 | 2017 | 872 | 0.060 |
Why?
|
| Quality of Life | 2 | 2023 | 13472 | 0.060 |
Why?
|
| Burkitt Lymphoma | 2 | 1984 | 338 | 0.060 |
Why?
|
| Risk | 1 | 2016 | 9601 | 0.060 |
Why?
|
| Genomic Structural Variation | 1 | 2024 | 80 | 0.060 |
Why?
|
| Aged, 80 and over | 7 | 2015 | 59538 | 0.060 |
Why?
|
| Autoradiography | 2 | 1995 | 725 | 0.060 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2005 | 259 | 0.060 |
Why?
|
| Viral Proteins | 1 | 2011 | 1801 | 0.060 |
Why?
|
| Demography | 1 | 2009 | 1641 | 0.060 |
Why?
|
| Embryo, Nonmammalian | 1 | 2007 | 910 | 0.060 |
Why?
|
| Organ Specificity | 4 | 2002 | 1966 | 0.060 |
Why?
|
| Reproducibility of Results | 4 | 2022 | 20129 | 0.060 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 1995 | 2426 | 0.060 |
Why?
|
| Arthrogryposis | 1 | 2004 | 69 | 0.050 |
Why?
|
| Pharmacogenetics | 1 | 2008 | 682 | 0.050 |
Why?
|
| RNA Splicing | 4 | 2021 | 903 | 0.050 |
Why?
|
| Histocompatibility Antigens Class II | 2 | 1987 | 1441 | 0.050 |
Why?
|
| Coitus | 1 | 2024 | 132 | 0.050 |
Why?
|
| Membrane Glycoproteins | 3 | 2000 | 3702 | 0.050 |
Why?
|
| Urinary Tract | 1 | 2007 | 305 | 0.050 |
Why?
|
| Fertilization in Vitro | 1 | 1991 | 1301 | 0.050 |
Why?
|
| Alanine Transaminase | 1 | 2006 | 608 | 0.050 |
Why?
|
| Acetyltransferases | 1 | 2004 | 230 | 0.050 |
Why?
|
| Self-Injurious Behavior | 1 | 2009 | 571 | 0.050 |
Why?
|
| Cell Line, Tumor | 3 | 2016 | 17082 | 0.050 |
Why?
|
| Chickens | 3 | 2000 | 842 | 0.050 |
Why?
|
| Vesico-Ureteral Reflux | 1 | 2007 | 433 | 0.050 |
Why?
|
| Growth Disorders | 2 | 2004 | 634 | 0.050 |
Why?
|
| Uridine | 1 | 1983 | 135 | 0.050 |
Why?
|
| Adenocarcinoma | 3 | 1991 | 6361 | 0.050 |
Why?
|
| Laboratories | 2 | 2016 | 462 | 0.050 |
Why?
|
| Body Height | 1 | 2009 | 1562 | 0.050 |
Why?
|
| Epidemiologic Studies | 1 | 2006 | 677 | 0.050 |
Why?
|
| China | 2 | 2019 | 2383 | 0.050 |
Why?
|
| Rad51 Recombinase | 1 | 2003 | 191 | 0.050 |
Why?
|
| Calcium Channels | 3 | 2000 | 622 | 0.050 |
Why?
|
| Sequence Analysis | 2 | 2005 | 240 | 0.050 |
Why?
|
| Receptors, GABA | 1 | 2004 | 312 | 0.050 |
Why?
|
| Photosensitizing Agents | 1 | 2006 | 627 | 0.050 |
Why?
|
| RNA, Ribosomal | 1 | 1983 | 227 | 0.050 |
Why?
|
| Neuropeptides | 1 | 2008 | 950 | 0.050 |
Why?
|
| Analysis of Variance | 1 | 2010 | 6212 | 0.050 |
Why?
|
| Receptors, Complement | 2 | 1997 | 254 | 0.050 |
Why?
|
| Pseudopseudohypoparathyroidism | 1 | 2001 | 8 | 0.050 |
Why?
|
| Cell Differentiation | 3 | 2016 | 11648 | 0.050 |
Why?
|
| RNA | 4 | 2004 | 2715 | 0.050 |
Why?
|
| DNA Ligases | 1 | 2001 | 81 | 0.050 |
Why?
|
| Face | 2 | 2004 | 1029 | 0.050 |
Why?
|
| Prevalence | 2 | 2018 | 15820 | 0.050 |
Why?
|
| Jews | 2 | 2021 | 359 | 0.050 |
Why?
|
| 3T3 Cells | 1 | 2003 | 1082 | 0.050 |
Why?
|
| Coffee | 1 | 2006 | 593 | 0.050 |
Why?
|
| Oculomotor Muscles | 1 | 2005 | 405 | 0.050 |
Why?
|
| Models, Genetic | 3 | 2009 | 3450 | 0.050 |
Why?
|
| Cognition Disorders | 1 | 2015 | 3967 | 0.050 |
Why?
|
| Chorionic Villi Sampling | 1 | 2001 | 35 | 0.050 |
Why?
|
| Taste Threshold | 1 | 1981 | 7 | 0.050 |
Why?
|
| Lymphangioma, Cystic | 1 | 2001 | 34 | 0.050 |
Why?
|
| COS Cells | 1 | 2003 | 1135 | 0.050 |
Why?
|
| Protein Biosynthesis | 4 | 2000 | 2094 | 0.050 |
Why?
|
| Thrombospondins | 2 | 1999 | 197 | 0.050 |
Why?
|
| Polycystic Kidney Diseases | 1 | 2002 | 133 | 0.050 |
Why?
|
| Genomic Imprinting | 2 | 2003 | 326 | 0.050 |
Why?
|
| Database Management Systems | 1 | 2022 | 263 | 0.050 |
Why?
|
| Gene Targeting | 1 | 2024 | 840 | 0.040 |
Why?
|
| Blastocyst | 1 | 2004 | 432 | 0.040 |
Why?
|
| Ions | 1 | 2001 | 254 | 0.040 |
Why?
|
| Lipomatosis, Multiple Symmetrical | 1 | 2000 | 8 | 0.040 |
Why?
|
| Cartilage | 2 | 1994 | 811 | 0.040 |
Why?
|
| Rana catesbeiana | 1 | 2000 | 85 | 0.040 |
Why?
|
| Receptors, Immunologic | 1 | 2007 | 1418 | 0.040 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2007 | 1657 | 0.040 |
Why?
|
| Acute Disease | 2 | 2008 | 7240 | 0.040 |
Why?
|
| Cells, Cultured | 8 | 2019 | 18979 | 0.040 |
Why?
|
| Catalase | 1 | 2000 | 215 | 0.040 |
Why?
|
| Twins, Dizygotic | 1 | 1981 | 236 | 0.040 |
Why?
|
| Organic Anion Transporters, Sodium-Dependent | 1 | 2000 | 26 | 0.040 |
Why?
|
| Chemotactic Factors | 2 | 1991 | 197 | 0.040 |
Why?
|
| Semen | 1 | 2022 | 349 | 0.040 |
Why?
|
| Hormones | 1 | 2024 | 866 | 0.040 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 3 | 1995 | 492 | 0.040 |
Why?
|
| Color | 1 | 2001 | 297 | 0.040 |
Why?
|
| Carcinoma, Hepatocellular | 2 | 2000 | 2329 | 0.040 |
Why?
|
| B-Lymphocytes | 2 | 2011 | 4784 | 0.040 |
Why?
|
| Taste | 1 | 1981 | 190 | 0.040 |
Why?
|
| Transfection | 3 | 2003 | 5750 | 0.040 |
Why?
|
| Receptors, Androgen | 2 | 1997 | 1089 | 0.040 |
Why?
|
| Neoplasms, Experimental | 1 | 2004 | 1227 | 0.040 |
Why?
|
| Mice, Mutant Strains | 2 | 2016 | 1750 | 0.040 |
Why?
|
| Severity of Illness Index | 2 | 2008 | 15897 | 0.040 |
Why?
|
| Sexual Partners | 1 | 2024 | 804 | 0.040 |
Why?
|
| Guanine Nucleotide Dissociation Inhibitors | 1 | 1998 | 23 | 0.040 |
Why?
|
| Vulvar Neoplasms | 1 | 2001 | 266 | 0.040 |
Why?
|
| Laparoscopy | 1 | 2010 | 2039 | 0.040 |
Why?
|
| Carcinoma, Papillary | 1 | 2004 | 791 | 0.040 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2003 | 701 | 0.040 |
Why?
|
| Staining and Labeling | 1 | 1983 | 1073 | 0.040 |
Why?
|
| Cystic Fibrosis | 1 | 1988 | 1284 | 0.040 |
Why?
|
| Aquaporins | 1 | 1999 | 176 | 0.040 |
Why?
|
| Databases, Genetic | 2 | 2022 | 1755 | 0.040 |
Why?
|
| Louisiana | 1 | 1998 | 104 | 0.040 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 1 | 2001 | 352 | 0.040 |
Why?
|
| Cell Proliferation | 2 | 2011 | 10438 | 0.040 |
Why?
|
| Suicide | 1 | 2009 | 1606 | 0.040 |
Why?
|
| Fluorescence | 1 | 2001 | 751 | 0.040 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2006 | 1814 | 0.040 |
Why?
|
| L-Aminoadipate-Semialdehyde Dehydrogenase | 1 | 1997 | 2 | 0.040 |
Why?
|
| Extracellular Matrix | 2 | 2007 | 1729 | 0.040 |
Why?
|
| Fibroblasts | 5 | 2007 | 4164 | 0.040 |
Why?
|
| Case-Control Studies | 6 | 2012 | 22245 | 0.040 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2001 | 737 | 0.040 |
Why?
|
| Drosophila melanogaster | 1 | 2007 | 1725 | 0.040 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2000 | 484 | 0.040 |
Why?
|
| Prader-Willi Syndrome | 1 | 1999 | 80 | 0.040 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 1986 | 1935 | 0.040 |
Why?
|
| Cognition | 1 | 2015 | 7057 | 0.040 |
Why?
|
| Anxiety | 1 | 2013 | 4671 | 0.040 |
Why?
|
| Gene Order | 2 | 2012 | 164 | 0.040 |
Why?
|
| Estrogen Receptor beta | 1 | 1998 | 171 | 0.040 |
Why?
|
| Meniere Disease | 1 | 1999 | 164 | 0.040 |
Why?
|
| Birth Weight | 1 | 2006 | 2123 | 0.040 |
Why?
|
| Proto-Oncogene Proteins | 3 | 2011 | 4521 | 0.040 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 1999 | 415 | 0.040 |
Why?
|
| Veins | 1 | 2002 | 770 | 0.040 |
Why?
|
| Kidney | 5 | 2007 | 7071 | 0.040 |
Why?
|
| Chemotactic Factors, Eosinophil | 1 | 1997 | 40 | 0.040 |
Why?
|
| Hypoxanthine Phosphoribosyltransferase | 1 | 1997 | 70 | 0.040 |
Why?
|
| Chorionic Gonadotropin | 1 | 1999 | 458 | 0.040 |
Why?
|
| Incidence | 2 | 2006 | 21509 | 0.040 |
Why?
|
| Rats | 6 | 2007 | 23718 | 0.040 |
Why?
|
| Protein Precursors | 1 | 2001 | 1134 | 0.030 |
Why?
|
| Aldehyde Dehydrogenase | 1 | 1997 | 146 | 0.030 |
Why?
|
| Blotting, Southern | 4 | 2007 | 774 | 0.030 |
Why?
|
| rho GTP-Binding Proteins | 1 | 1998 | 279 | 0.030 |
Why?
|
| Mannose-Binding Lectin | 1 | 1998 | 146 | 0.030 |
Why?
|
| Ploidies | 2 | 1995 | 287 | 0.030 |
Why?
|
| HMGA1a Protein | 1 | 1997 | 63 | 0.030 |
Why?
|
| Costa Rica | 1 | 1997 | 187 | 0.030 |
Why?
|
| Angelman Syndrome | 1 | 1999 | 139 | 0.030 |
Why?
|
| Retina | 4 | 2002 | 2656 | 0.030 |
Why?
|
| Cohort Studies | 3 | 2021 | 41703 | 0.030 |
Why?
|
| Liver Neoplasms | 2 | 2000 | 4356 | 0.030 |
Why?
|
| Deoxyribonuclease I | 1 | 1997 | 228 | 0.030 |
Why?
|
| Ascorbic Acid | 1 | 2000 | 658 | 0.030 |
Why?
|
| Blood Vessels | 1 | 2002 | 1111 | 0.030 |
Why?
|
| Apraxias | 1 | 2016 | 58 | 0.030 |
Why?
|
| Cell Movement | 2 | 2011 | 5197 | 0.030 |
Why?
|
| T-Box Domain Proteins | 1 | 1999 | 471 | 0.030 |
Why?
|
| Metaphase | 4 | 1991 | 143 | 0.030 |
Why?
|
| Endodeoxyribonucleases | 1 | 1997 | 165 | 0.030 |
Why?
|
| Carcinoma in Situ | 1 | 2002 | 784 | 0.030 |
Why?
|
| Chemokines, CC | 1 | 1997 | 285 | 0.030 |
Why?
|
| Avian Proteins | 1 | 1996 | 77 | 0.030 |
Why?
|
| Cathepsins | 1 | 1997 | 243 | 0.030 |
Why?
|
| Pulse | 1 | 1996 | 217 | 0.030 |
Why?
|
| Mydriatics | 1 | 1996 | 67 | 0.030 |
Why?
|
| Epilepsy | 1 | 2011 | 3317 | 0.030 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 2 | 1995 | 780 | 0.030 |
Why?
|
| Biological Transport | 2 | 1997 | 2083 | 0.030 |
Why?
|
| Heparin | 1 | 2003 | 1634 | 0.030 |
Why?
|
| Respiratory Tract Infections | 1 | 2003 | 1008 | 0.030 |
Why?
|
| Perilymph | 1 | 1995 | 50 | 0.030 |
Why?
|
| Bipolar Disorder | 1 | 2013 | 5130 | 0.030 |
Why?
|
| Receptors, Calcitonin | 1 | 1995 | 33 | 0.030 |
Why?
|
| Liver Cirrhosis | 1 | 2006 | 1960 | 0.030 |
Why?
|
| Models, Anatomic | 1 | 1999 | 678 | 0.030 |
Why?
|
| Micrognathism | 1 | 2016 | 64 | 0.030 |
Why?
|
| Rats, Inbred WKY | 1 | 1995 | 150 | 0.030 |
Why?
|
| Genistein | 1 | 1995 | 87 | 0.030 |
Why?
|
| Rats, Inbred SHR | 1 | 1995 | 187 | 0.030 |
Why?
|
| Pathology | 1 | 1998 | 270 | 0.030 |
Why?
|
| DNA Damage | 2 | 2002 | 2464 | 0.030 |
Why?
|
| Recombination, Genetic | 5 | 2002 | 1525 | 0.030 |
Why?
|
| DNA Helicases | 1 | 2000 | 853 | 0.030 |
Why?
|
| Vision Screening | 1 | 1996 | 72 | 0.030 |
Why?
|
| Wnt Proteins | 2 | 2011 | 721 | 0.030 |
Why?
|
| Sensitivity and Specificity | 3 | 2006 | 14643 | 0.030 |
Why?
|
| Chorionic Villi | 1 | 1995 | 53 | 0.030 |
Why?
|
| Second Messenger Systems | 1 | 1995 | 203 | 0.030 |
Why?
|
| Mesoderm | 3 | 1995 | 679 | 0.030 |
Why?
|
| Avidin | 1 | 1994 | 44 | 0.030 |
Why?
|
| Chorion | 1 | 1995 | 113 | 0.030 |
Why?
|
| Stem Cells | 2 | 2006 | 3538 | 0.030 |
Why?
|
| Specialty Boards | 1 | 2016 | 235 | 0.030 |
Why?
|
| Cell Compartmentation | 1 | 1995 | 383 | 0.030 |
Why?
|
| Isoflavones | 1 | 1995 | 139 | 0.030 |
Why?
|
| Substrate Specificity | 2 | 1995 | 1749 | 0.030 |
Why?
|
| Family | 1 | 2005 | 3209 | 0.030 |
Why?
|
| Amino Acids, Dicarboxylic | 1 | 1994 | 23 | 0.030 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2002 | 1097 | 0.030 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2019 | 1331 | 0.030 |
Why?
|
| Amyloid | 1 | 2019 | 848 | 0.030 |
Why?
|
| Autoimmune Diseases | 1 | 2006 | 2249 | 0.030 |
Why?
|
| Carcinogens, Environmental | 1 | 1994 | 70 | 0.030 |
Why?
|
| Causality | 1 | 2000 | 1251 | 0.030 |
Why?
|
| Sexual Behavior | 1 | 2024 | 2192 | 0.030 |
Why?
|
| Awards and Prizes | 1 | 1998 | 365 | 0.030 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1996 | 1729 | 0.030 |
Why?
|
| Patient Satisfaction | 1 | 2006 | 3485 | 0.030 |
Why?
|
| Hair | 1 | 1997 | 508 | 0.030 |
Why?
|
| Calcitonin | 1 | 1995 | 326 | 0.030 |
Why?
|
| Socioeconomic Factors | 1 | 2008 | 7840 | 0.030 |
Why?
|
| Minisatellite Repeats | 1 | 1994 | 162 | 0.030 |
Why?
|
| DNA Methylation | 2 | 1999 | 4428 | 0.030 |
Why?
|
| Chromium | 1 | 1994 | 133 | 0.030 |
Why?
|
| Biological Evolution | 4 | 1994 | 1075 | 0.030 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 1989 | 4049 | 0.030 |
Why?
|
| Amidohydrolases | 1 | 1994 | 160 | 0.030 |
Why?
|
| Amnion | 1 | 1995 | 204 | 0.030 |
Why?
|
| Interleukin-17 | 1 | 2019 | 923 | 0.030 |
Why?
|
| Amino Acid Oxidoreductases | 1 | 1994 | 149 | 0.030 |
Why?
|
| Biotin | 1 | 1994 | 255 | 0.030 |
Why?
|
| Retinal Cone Photoreceptor Cells | 1 | 1995 | 183 | 0.030 |
Why?
|
| Audiometry, Pure-Tone | 2 | 2005 | 210 | 0.030 |
Why?
|
| CpG Islands | 2 | 2011 | 1208 | 0.030 |
Why?
|
| Cell Adhesion | 2 | 2011 | 3093 | 0.030 |
Why?
|
| Logistic Models | 1 | 2008 | 13276 | 0.030 |
Why?
|
| DNA Repair | 1 | 2002 | 2048 | 0.030 |
Why?
|
| Breast | 1 | 2002 | 1971 | 0.030 |
Why?
|
| Immunologic Memory | 1 | 2019 | 1377 | 0.030 |
Why?
|
| Stereoisomerism | 1 | 2013 | 612 | 0.030 |
Why?
|
| Suppression, Genetic | 1 | 2013 | 190 | 0.030 |
Why?
|
| Interleukin-2 | 1 | 1999 | 1894 | 0.030 |
Why?
|
| Dermatitis, Allergic Contact | 1 | 1994 | 112 | 0.030 |
Why?
|
| Young Adult | 3 | 2016 | 59928 | 0.030 |
Why?
|
| Cerebral Ventricle Neoplasms | 1 | 1992 | 43 | 0.030 |
Why?
|
| Endothelium, Vascular | 1 | 2004 | 4417 | 0.030 |
Why?
|
| Prognosis | 2 | 2019 | 29922 | 0.020 |
Why?
|
| Oligonucleotide Probes | 2 | 1990 | 416 | 0.020 |
Why?
|
| Cytodiagnosis | 1 | 2016 | 450 | 0.020 |
Why?
|
| Tumor Suppressor Proteins | 2 | 1999 | 2799 | 0.020 |
Why?
|
| Artifacts | 1 | 2001 | 1896 | 0.020 |
Why?
|
| Thrombosis | 1 | 2006 | 2950 | 0.020 |
Why?
|
| Mental Disorders | 1 | 2012 | 6869 | 0.020 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2001 | 1836 | 0.020 |
Why?
|
| Xenopus laevis | 3 | 2000 | 965 | 0.020 |
Why?
|
| Crosses, Genetic | 3 | 1999 | 752 | 0.020 |
Why?
|
| Core Binding Factor alpha Subunits | 1 | 2011 | 25 | 0.020 |
Why?
|
| Hawaii | 1 | 1991 | 101 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2002 | 2947 | 0.020 |
Why?
|
| DNA Restriction Enzymes | 3 | 1986 | 548 | 0.020 |
Why?
|
| Immunoglobulins | 2 | 1985 | 853 | 0.020 |
Why?
|
| Placental Hormones | 1 | 1990 | 11 | 0.020 |
Why?
|
| DNA Breaks | 1 | 2011 | 47 | 0.020 |
Why?
|
| Wilms Tumor | 1 | 1994 | 378 | 0.020 |
Why?
|
| Species Specificity | 3 | 2009 | 2413 | 0.020 |
Why?
|
| Electroencephalography | 1 | 2007 | 6282 | 0.020 |
Why?
|
| Retinopathy of Prematurity | 1 | 1996 | 449 | 0.020 |
Why?
|
| Muscle Proteins | 1 | 1996 | 1160 | 0.020 |
Why?
|
| Interspersed Repetitive Sequences | 1 | 2011 | 52 | 0.020 |
Why?
|
| Pituitary Neoplasms | 1 | 1999 | 1324 | 0.020 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 1 | 1994 | 283 | 0.020 |
Why?
|
| Treatment Outcome | 3 | 2023 | 65202 | 0.020 |
Why?
|
| Abortion, Spontaneous | 1 | 2016 | 536 | 0.020 |
Why?
|
| RNA, Antisense | 1 | 1991 | 135 | 0.020 |
Why?
|
| Proteomics | 1 | 2004 | 3906 | 0.020 |
Why?
|
| AMP Deaminase | 1 | 1990 | 5 | 0.020 |
Why?
|
| Nucleotide Deaminases | 1 | 1990 | 11 | 0.020 |
Why?
|
| Polyps | 1 | 1992 | 200 | 0.020 |
Why?
|
| Brain | 5 | 2000 | 27156 | 0.020 |
Why?
|
| Protein Folding | 1 | 2014 | 868 | 0.020 |
Why?
|
| Cell Nucleus | 2 | 1999 | 2869 | 0.020 |
Why?
|
| Thyroid Neoplasms | 1 | 2004 | 2355 | 0.020 |
Why?
|
| Neoplasms | 3 | 2016 | 22343 | 0.020 |
Why?
|
| Isoenzymes | 1 | 1995 | 1688 | 0.020 |
Why?
|
| Sodium Channels | 1 | 2012 | 339 | 0.020 |
Why?
|
| Sarcoma | 1 | 2001 | 1802 | 0.020 |
Why?
|
| Golgi Apparatus | 1 | 2012 | 405 | 0.020 |
Why?
|
| Up-Regulation | 1 | 1999 | 4141 | 0.020 |
Why?
|
| Eye | 1 | 1994 | 710 | 0.020 |
Why?
|
| Homeostasis | 1 | 2001 | 3341 | 0.020 |
Why?
|
| Granulosa Cell Tumor | 1 | 1991 | 76 | 0.020 |
Why?
|
| Vimentin | 1 | 1991 | 257 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-ets | 1 | 2011 | 313 | 0.020 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 1995 | 857 | 0.020 |
Why?
|
| Collagen Type I | 1 | 1993 | 616 | 0.020 |
Why?
|
| Transcription Factor RelA | 1 | 2011 | 252 | 0.020 |
Why?
|
| Gene Rearrangement, T-Lymphocyte | 1 | 1990 | 111 | 0.020 |
Why?
|
| Ribonuclease, Pancreatic | 1 | 1990 | 112 | 0.020 |
Why?
|
| Mitosis | 1 | 1995 | 1176 | 0.020 |
Why?
|
| Ligands | 2 | 2013 | 3276 | 0.020 |
Why?
|
| Profilins | 1 | 1990 | 65 | 0.020 |
Why?
|
| MicroRNAs | 1 | 2006 | 3788 | 0.020 |
Why?
|
| Ribonucleases | 1 | 1990 | 266 | 0.020 |
Why?
|
| Physical Examination | 1 | 1996 | 1265 | 0.020 |
Why?
|
| DNA Barcoding, Taxonomic | 1 | 2011 | 134 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 2019 | 3400 | 0.020 |
Why?
|
| Oligopeptides | 1 | 1995 | 1195 | 0.020 |
Why?
|
| Lymphoma, T-Cell, Cutaneous | 1 | 1992 | 210 | 0.020 |
Why?
|
| Lung Neoplasms | 3 | 1991 | 13486 | 0.020 |
Why?
|
| Lymphocyte Function-Associated Antigen-1 | 2 | 1988 | 381 | 0.020 |
Why?
|
| Keratins | 1 | 1991 | 499 | 0.020 |
Why?
|
| Immunoglobulin Heavy Chains | 2 | 1982 | 647 | 0.020 |
Why?
|
| Subcellular Fractions | 2 | 2002 | 526 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 1995 | 3585 | 0.020 |
Why?
|
| Prospective Studies | 3 | 2023 | 54826 | 0.020 |
Why?
|
| Molecular Structure | 1 | 2013 | 1881 | 0.020 |
Why?
|
| Tropical Climate | 1 | 2009 | 35 | 0.020 |
Why?
|
| Ependymoma | 1 | 1992 | 326 | 0.020 |
Why?
|
| Central America | 1 | 2009 | 69 | 0.020 |
Why?
|
| Amniocentesis | 2 | 2001 | 116 | 0.020 |
Why?
|
| Leukemia-Lymphoma, Adult T-Cell | 1 | 1990 | 167 | 0.020 |
Why?
|
| Muscles | 2 | 1991 | 1576 | 0.020 |
Why?
|
| Antigens, Differentiation, B-Lymphocyte | 1 | 1989 | 317 | 0.020 |
Why?
|
| Muridae | 2 | 2001 | 55 | 0.020 |
Why?
|
| Angiogenesis Inducing Agents | 1 | 1990 | 253 | 0.020 |
Why?
|
| Open Reading Frames | 1 | 1992 | 818 | 0.020 |
Why?
|
| Nervous System | 1 | 2012 | 542 | 0.020 |
Why?
|
| Cricetinae | 4 | 2001 | 2416 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 5 | 1999 | 5789 | 0.020 |
Why?
|
| Pulmonary Surfactants | 1 | 1989 | 169 | 0.020 |
Why?
|
| South America | 1 | 2009 | 180 | 0.020 |
Why?
|
| Disease Management | 1 | 2019 | 2530 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 2019 | 5502 | 0.020 |
Why?
|
| Ontario | 1 | 2009 | 403 | 0.020 |
Why?
|
| Myelodysplastic Syndromes | 1 | 1998 | 1404 | 0.020 |
Why?
|
| Acute-Phase Proteins | 1 | 1989 | 251 | 0.020 |
Why?
|
| Lymphoproliferative Disorders | 1 | 1992 | 527 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2015 | 1505 | 0.020 |
Why?
|
| T-Lymphocytes | 5 | 1999 | 10263 | 0.020 |
Why?
|
| Chromosomes, Artificial, Yeast | 2 | 1998 | 113 | 0.020 |
Why?
|
| Osteoblasts | 1 | 1993 | 1143 | 0.020 |
Why?
|
| Chromosomes, Human, 21-22 and Y | 2 | 1986 | 45 | 0.020 |
Why?
|
| Axons | 1 | 2016 | 1675 | 0.020 |
Why?
|
| Genetic Loci | 1 | 2017 | 2630 | 0.020 |
Why?
|
| Genes, Tumor Suppressor | 1 | 1992 | 1058 | 0.020 |
Why?
|
| Rhabdomyosarcoma | 1 | 1991 | 358 | 0.020 |
Why?
|
| Hypertension | 1 | 2008 | 8614 | 0.020 |
Why?
|
| Tubulin | 1 | 2011 | 694 | 0.020 |
Why?
|
| Reference Values | 1 | 1995 | 4913 | 0.020 |
Why?
|
| Gelsolin | 1 | 1988 | 189 | 0.020 |
Why?
|
| Nucleosomes | 1 | 2011 | 492 | 0.020 |
Why?
|
| Phosphorylation | 2 | 1995 | 8300 | 0.020 |
Why?
|
| Immunoglobulin kappa-Chains | 1 | 1988 | 171 | 0.020 |
Why?
|
| Neurilemmoma | 1 | 1992 | 522 | 0.020 |
Why?
|
| Calcium | 1 | 2000 | 5781 | 0.020 |
Why?
|
| Recombinant Proteins | 3 | 2006 | 6507 | 0.020 |
Why?
|
| Genome, Viral | 1 | 2011 | 674 | 0.020 |
Why?
|
| Macrophage-1 Antigen | 1 | 1988 | 286 | 0.020 |
Why?
|
| Macular Degeneration | 1 | 1995 | 1015 | 0.020 |
Why?
|
| Otoacoustic Emissions, Spontaneous | 1 | 2007 | 139 | 0.020 |
Why?
|
| Lymphokines | 1 | 1990 | 924 | 0.020 |
Why?
|
| Vaccination | 1 | 2019 | 3434 | 0.020 |
Why?
|
| Animals, Genetically Modified | 1 | 2012 | 1562 | 0.020 |
Why?
|
| TRPP Cation Channels | 2 | 1998 | 177 | 0.020 |
Why?
|
| Immunoglobulin J-Chains | 1 | 1986 | 26 | 0.020 |
Why?
|
| Aqueous Humor | 1 | 2007 | 152 | 0.020 |
Why?
|
| Carcinoma, Small Cell | 1 | 1989 | 419 | 0.020 |
Why?
|
| Geography | 1 | 2009 | 651 | 0.020 |
Why?
|
| Risk Assessment | 2 | 2006 | 24272 | 0.020 |
Why?
|
| Registries | 1 | 2023 | 8344 | 0.020 |
Why?
|
| Muscle, Smooth | 1 | 1990 | 931 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2002 | 8061 | 0.020 |
Why?
|
| Corticotropin-Releasing Hormone | 1 | 1988 | 362 | 0.020 |
Why?
|
| HLA-DR Antigens | 2 | 1986 | 609 | 0.020 |
Why?
|
| Palate | 1 | 2006 | 126 | 0.020 |
Why?
|
| Endoplasmic Reticulum | 1 | 2012 | 1132 | 0.020 |
Why?
|
| Cytoplasm | 2 | 2002 | 1505 | 0.020 |
Why?
|
| Receptors, Fc | 1 | 1989 | 537 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2015 | 6327 | 0.020 |
Why?
|
| Occupational Diseases | 1 | 1994 | 1456 | 0.020 |
Why?
|
| Mutant Chimeric Proteins | 1 | 2005 | 19 | 0.020 |
Why?
|
| Mutagenesis | 2 | 2001 | 1228 | 0.020 |
Why?
|
| Bone Marrow | 1 | 2016 | 2926 | 0.020 |
Why?
|
| Histocompatibility Antigens | 1 | 1987 | 479 | 0.020 |
Why?
|
| Phosphoglycerate Kinase | 1 | 1985 | 66 | 0.020 |
Why?
|
| Retrospective Studies | 3 | 2022 | 81588 | 0.020 |
Why?
|
| Microtubules | 1 | 2011 | 1062 | 0.020 |
Why?
|
| Leukemia | 2 | 1985 | 1521 | 0.020 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 1988 | 616 | 0.020 |
Why?
|
| Neural Stem Cells | 1 | 2012 | 895 | 0.020 |
Why?
|
| Calcium Channels, L-Type | 1 | 2007 | 243 | 0.020 |
Why?
|
| Leucine Zippers | 2 | 1996 | 116 | 0.020 |
Why?
|
| Pregnancy Outcome | 2 | 1997 | 2970 | 0.020 |
Why?
|
| Audiometry | 1 | 2005 | 253 | 0.010 |
Why?
|
| Oocytes | 2 | 2000 | 1168 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 1995 | 3721 | 0.010 |
Why?
|
| Research Personnel | 1 | 2009 | 589 | 0.010 |
Why?
|
| Ureter | 1 | 2007 | 364 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2001 | 9243 | 0.010 |
Why?
|
| Cell Aggregation | 1 | 2004 | 238 | 0.010 |
Why?
|
| Macromolecular Substances | 3 | 1995 | 1431 | 0.010 |
Why?
|
| Hodgkin Disease | 1 | 1992 | 1384 | 0.010 |
Why?
|
| Peer Review, Research | 1 | 2007 | 343 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2006 | 2884 | 0.010 |
Why?
|
| Repressor Proteins | 1 | 1995 | 2977 | 0.010 |
Why?
|
| Genetic Techniques | 1 | 1986 | 428 | 0.010 |
Why?
|
| Actins | 1 | 2011 | 2060 | 0.010 |
Why?
|
| Mass Screening | 1 | 1999 | 5451 | 0.010 |
Why?
|
| Occupational Exposure | 1 | 1994 | 1807 | 0.010 |
Why?
|
| Mice, Inbred DBA | 1 | 2004 | 624 | 0.010 |
Why?
|
| Drosophila | 1 | 2011 | 1507 | 0.010 |
Why?
|
| Neoplasm Invasiveness | 2 | 2003 | 3608 | 0.010 |
Why?
|
| Chromosome Fragility | 1 | 2003 | 16 | 0.010 |
Why?
|
| Serine Endopeptidases | 1 | 1989 | 1027 | 0.010 |
Why?
|
| Chromosome Fragile Sites | 1 | 2003 | 26 | 0.010 |
Why?
|
| Skin Diseases | 1 | 1992 | 1083 | 0.010 |
Why?
|
| Genes, Overlapping | 1 | 2003 | 36 | 0.010 |
Why?
|
| Mitochondria | 1 | 2017 | 3676 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2019 | 8042 | 0.010 |
Why?
|
| Protein Phosphatase 2 | 2 | 1995 | 231 | 0.010 |
Why?
|
| Centrosome | 1 | 2004 | 209 | 0.010 |
Why?
|
| Nervous System Diseases | 1 | 1994 | 1659 | 0.010 |
Why?
|
| Immunoprecipitation | 1 | 2005 | 873 | 0.010 |
Why?
|
| Thymus Gland | 2 | 1999 | 1260 | 0.010 |
Why?
|
| Endometrial Neoplasms | 1 | 1992 | 1380 | 0.010 |
Why?
|
| Follow-Up Studies | 2 | 2019 | 39283 | 0.010 |
Why?
|
| Epithelium | 2 | 2002 | 1606 | 0.010 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2006 | 827 | 0.010 |
Why?
|
| Age of Onset | 2 | 2001 | 3342 | 0.010 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 1986 | 548 | 0.010 |
Why?
|
| Genes, RAG-1 | 1 | 2002 | 68 | 0.010 |
Why?
|
| Cesarean Section | 1 | 1991 | 1418 | 0.010 |
Why?
|
| Heart Ventricles | 1 | 2015 | 3821 | 0.010 |
Why?
|
| Histone Acetyltransferases | 1 | 2004 | 332 | 0.010 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2003 | 463 | 0.010 |
Why?
|
| Cell Division | 2 | 2003 | 4474 | 0.010 |
Why?
|
| Mast Cells | 1 | 1989 | 1405 | 0.010 |
Why?
|
| Cooperative Behavior | 1 | 2009 | 1512 | 0.010 |
Why?
|
| Homozygote | 2 | 1997 | 1774 | 0.010 |
Why?
|
| Plasmacytoma | 1 | 1982 | 171 | 0.010 |
Why?
|
| Gene Dosage | 1 | 2006 | 1211 | 0.010 |
Why?
|
| Cytokines | 1 | 1997 | 7436 | 0.010 |
Why?
|
| Abnormalities, Severe Teratoid | 1 | 1981 | 5 | 0.010 |
Why?
|
| Soft Tissue Neoplasms | 1 | 1991 | 1163 | 0.010 |
Why?
|
| Tumor Suppressor Protein p14ARF | 1 | 2001 | 84 | 0.010 |
Why?
|
| Retroelements | 1 | 2003 | 163 | 0.010 |
Why?
|
| Glycosaminoglycans | 1 | 2004 | 611 | 0.010 |
Why?
|
| Radiation Hybrid Mapping | 1 | 2001 | 16 | 0.010 |
Why?
|
| Quinacrine Mustard | 1 | 1981 | 2 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 1996 | 4966 | 0.010 |
Why?
|
| Phenylthiourea | 1 | 1981 | 10 | 0.010 |
Why?
|
| Fingers | 1 | 2004 | 508 | 0.010 |
Why?
|
| S100 Proteins | 1 | 2002 | 215 | 0.010 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 1990 | 1336 | 0.010 |
Why?
|
| Chromosomes, Artificial, Bacterial | 1 | 2001 | 125 | 0.010 |
Why?
|
| Caspase 3 | 1 | 2003 | 730 | 0.010 |
Why?
|
| Williams Syndrome | 1 | 2003 | 195 | 0.010 |
Why?
|
| Fatal Outcome | 1 | 2005 | 1838 | 0.010 |
Why?
|
| Adenovirus E1A Proteins | 1 | 2000 | 81 | 0.010 |
Why?
|
| Cell Cycle | 2 | 1999 | 2925 | 0.010 |
Why?
|
| Skin | 1 | 1994 | 4498 | 0.010 |
Why?
|
| Bayes Theorem | 1 | 2009 | 2352 | 0.010 |
Why?
|
| Pregnancy, High-Risk | 1 | 2001 | 121 | 0.010 |
Why?
|
| Anus, Imperforate | 1 | 1981 | 63 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 18 | 1 | 2001 | 247 | 0.010 |
Why?
|
| Blood Pressure | 1 | 1996 | 8532 | 0.010 |
Why?
|
| Cattle | 2 | 1997 | 3814 | 0.010 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2004 | 594 | 0.010 |
Why?
|
| Brain Stem | 1 | 2005 | 858 | 0.010 |
Why?
|
| Melanoma | 1 | 1999 | 5699 | 0.010 |
Why?
|
| Caspases | 1 | 2003 | 881 | 0.010 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2001 | 252 | 0.010 |
Why?
|
| False Negative Reactions | 1 | 2001 | 570 | 0.010 |
Why?
|
| Peptides | 1 | 1992 | 4344 | 0.010 |
Why?
|
| Biological Transport, Active | 1 | 2000 | 323 | 0.010 |
Why?
|
| Solar System | 1 | 1999 | 12 | 0.010 |
Why?
|
| Consanguinity | 2 | 1997 | 460 | 0.010 |
Why?
|
| Binomial Distribution | 1 | 1999 | 23 | 0.010 |
Why?
|
| Diabetes Insipidus | 1 | 1999 | 144 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 2004 | 2675 | 0.010 |
Why?
|
| Scotland | 1 | 1999 | 142 | 0.010 |
Why?
|
| Spinal Cord | 1 | 2007 | 1811 | 0.010 |
Why?
|
| TRPV Cation Channels | 1 | 2000 | 243 | 0.010 |
Why?
|
| Origin Recognition Complex | 1 | 1998 | 20 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2013 | 3446 | 0.010 |
Why?
|
| CHO Cells | 1 | 2001 | 1376 | 0.010 |
Why?
|
| Cosmids | 1 | 1998 | 105 | 0.010 |
Why?
|
| Replication Origin | 1 | 1998 | 77 | 0.010 |
Why?
|
| False Positive Reactions | 1 | 2001 | 957 | 0.010 |
Why?
|
| Transcription Factor Brn-3C | 1 | 1998 | 12 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2001 | 703 | 0.010 |
Why?
|
| Binding Sites | 2 | 1997 | 6010 | 0.010 |
Why?
|
| Mice, Nude | 1 | 2004 | 3610 | 0.010 |
Why?
|
| Puberty, Precocious | 1 | 1999 | 165 | 0.010 |
Why?
|
| Epigenesis, Genetic | 1 | 2011 | 3824 | 0.010 |
Why?
|
| Myocardium | 1 | 1990 | 4763 | 0.010 |
Why?
|
| HeLa Cells | 2 | 1999 | 3072 | 0.010 |
Why?
|
| Chemokine CCL11 | 1 | 1997 | 127 | 0.010 |
Why?
|
| Cathepsin K | 1 | 1997 | 65 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2003 | 10740 | 0.010 |
Why?
|
| Seminiferous Tubules | 1 | 1996 | 25 | 0.010 |
Why?
|
| Structure-Activity Relationship | 2 | 1995 | 3053 | 0.010 |
Why?
|
| Proline | 1 | 1999 | 454 | 0.010 |
Why?
|
| Laminin | 1 | 1998 | 404 | 0.010 |
Why?
|
| Cyclopentolate | 1 | 1996 | 6 | 0.010 |
Why?
|
| Peptide Chain Initiation, Translational | 1 | 1997 | 100 | 0.010 |
Why?
|
| Complement C1q | 1 | 1997 | 93 | 0.010 |
Why?
|
| Mice, SCID | 1 | 2001 | 2626 | 0.010 |
Why?
|
| Receptor-Like Protein Tyrosine Phosphatases, Class 4 | 1 | 1996 | 8 | 0.010 |
Why?
|
| Alagille Syndrome | 1 | 1996 | 45 | 0.010 |
Why?
|
| Procaine | 1 | 1996 | 60 | 0.010 |
Why?
|
| Xanthines | 1 | 1996 | 121 | 0.010 |
Why?
|
| Zinc Fingers | 1 | 1998 | 577 | 0.010 |
Why?
|
| Pesticides | 1 | 1999 | 297 | 0.010 |
Why?
|
| Poly A | 2 | 1988 | 180 | 0.010 |
Why?
|
| Dual Specificity Phosphatase 2 | 1 | 1995 | 5 | 0.010 |
Why?
|
| Israel | 1 | 1998 | 722 | 0.010 |
Why?
|
| Lymphoma, B-Cell | 1 | 2002 | 943 | 0.010 |
Why?
|
| Phenylephrine | 1 | 1996 | 292 | 0.010 |
Why?
|
| Chimera | 1 | 1996 | 455 | 0.010 |
Why?
|
| Fushi Tarazu Transcription Factors | 1 | 1995 | 24 | 0.010 |
Why?
|
| Giant Cell Tumors | 1 | 1995 | 89 | 0.010 |
Why?
|
| Australia | 1 | 1999 | 1262 | 0.010 |
Why?
|
| Steroidogenic Factor 1 | 1 | 1995 | 45 | 0.010 |
Why?
|
| Ribosomal Protein S6 Kinases | 1 | 1995 | 203 | 0.010 |
Why?
|
| Serine | 1 | 1999 | 829 | 0.010 |
Why?
|
| Liver | 1 | 1991 | 7570 | 0.010 |
Why?
|
| Protein Structure, Secondary | 1 | 1998 | 1211 | 0.010 |
Why?
|
| Blood Gas Analysis | 1 | 1996 | 382 | 0.010 |
Why?
|
| Cell Lineage | 1 | 2004 | 2573 | 0.010 |
Why?
|
| Epithelial Cells | 2 | 2002 | 3689 | 0.010 |
Why?
|
| Biotinidase | 1 | 1994 | 17 | 0.010 |
Why?
|
| Foot | 1 | 1999 | 576 | 0.010 |
Why?
|
| Fibronectins | 1 | 1998 | 722 | 0.010 |
Why?
|
| Amino Acid Substitution | 1 | 1999 | 1742 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 1981 | 2351 | 0.010 |
Why?
|
| Amino Acid Transport System X-AG | 1 | 1994 | 38 | 0.010 |
Why?
|
| Genes, Wilms Tumor | 1 | 1994 | 92 | 0.010 |
Why?
|
| Patch Tests | 1 | 1994 | 57 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 2002 | 1927 | 0.010 |
Why?
|
| MafK Transcription Factor | 1 | 1993 | 8 | 0.010 |
Why?
|
| NF-E2 Transcription Factor | 1 | 1993 | 38 | 0.010 |
Why?
|
| Ovarian Neoplasms | 1 | 1991 | 4904 | 0.010 |
Why?
|
| NF-E2 Transcription Factor, p45 Subunit | 1 | 1993 | 53 | 0.010 |
Why?
|
| PTEN Phosphohydrolase | 1 | 1999 | 1117 | 0.010 |
Why?
|
| Spine | 1 | 1981 | 1134 | 0.010 |
Why?
|
| Psoriasis | 1 | 2002 | 925 | 0.010 |
Why?
|
| Erythroid-Specific DNA-Binding Factors | 1 | 1993 | 195 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 1995 | 478 | 0.010 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 1995 | 327 | 0.010 |
Why?
|
| Mice, Inbred C3H | 1 | 1995 | 915 | 0.010 |
Why?
|
| Hand | 1 | 1999 | 909 | 0.010 |
Why?
|
| Consensus Sequence | 1 | 1994 | 363 | 0.010 |
Why?
|
| Schizophrenia | 1 | 2012 | 6975 | 0.010 |
Why?
|
| Growth Substances | 1 | 1995 | 759 | 0.010 |
Why?
|
| Radiotherapy | 1 | 1999 | 1497 | 0.010 |
Why?
|
| Adrenal Insufficiency | 1 | 1995 | 194 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 1999 | 3427 | 0.010 |
Why?
|
| Genes, Neurofibromatosis 1 | 1 | 1992 | 75 | 0.010 |
Why?
|
| Down Syndrome | 1 | 2001 | 916 | 0.010 |
Why?
|
| Deoxyribonuclease EcoRI | 1 | 1992 | 30 | 0.010 |
Why?
|
| Kidney Neoplasms | 2 | 1986 | 4282 | 0.010 |
Why?
|
| Amino Acid Transport Systems, Basic | 1 | 1992 | 35 | 0.010 |
Why?
|
| Rodentia | 1 | 1994 | 262 | 0.010 |
Why?
|
| Kinetics | 1 | 2000 | 6285 | 0.010 |
Why?
|
| Genes, ras | 1 | 1995 | 657 | 0.010 |
Why?
|
| Reed-Sternberg Cells | 1 | 1992 | 78 | 0.010 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1993 | 705 | 0.010 |
Why?
|
| DNA Replication | 1 | 1998 | 1426 | 0.010 |
Why?
|
| Carcinoma, Renal Cell | 1 | 1986 | 3186 | 0.010 |
Why?
|
| Macaca mulatta | 1 | 1998 | 2341 | 0.010 |
Why?
|
| Cyclic AMP | 1 | 1995 | 1472 | 0.010 |
Why?
|
| Recurrence | 1 | 2003 | 8478 | 0.010 |
Why?
|
| Mitochondrial Proteins | 1 | 1997 | 979 | 0.010 |
Why?
|
| Nitric Oxide Synthase | 1 | 1994 | 911 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 1995 | 12236 | 0.010 |
Why?
|
| Spleen | 1 | 1996 | 2294 | 0.010 |
Why?
|
| Diploidy | 1 | 1990 | 140 | 0.010 |
Why?
|
| Flow Cytometry | 2 | 1991 | 5890 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2000 | 5385 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2001 | 8107 | 0.010 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 1 | 1989 | 167 | 0.010 |
Why?
|
| Complement Factor I | 1 | 1989 | 14 | 0.010 |
Why?
|
| Mannose-Binding Lectins | 1 | 1989 | 100 | 0.010 |
Why?
|
| Transcriptional Activation | 1 | 1995 | 1749 | 0.010 |
Why?
|
| Anesthetics, Local | 1 | 1996 | 1005 | 0.010 |
Why?
|
| Cytological Techniques | 1 | 1991 | 217 | 0.000 |
Why?
|
| Genes, Synthetic | 1 | 1989 | 88 | 0.000 |
Why?
|
| Chemokine CCL2 | 1 | 1991 | 604 | 0.000 |
Why?
|
| Hematologic Neoplasms | 1 | 2000 | 1926 | 0.000 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 1992 | 812 | 0.000 |
Why?
|
| Immunoglobulin Joining Region | 1 | 1988 | 37 | 0.000 |
Why?
|
| Receptors, IgE | 1 | 1989 | 375 | 0.000 |
Why?
|
| Isoelectric Point | 1 | 1987 | 76 | 0.000 |
Why?
|
| Protein Binding | 1 | 1999 | 9315 | 0.000 |
Why?
|
| Interleukin-8 | 1 | 1990 | 701 | 0.000 |
Why?
|
| Apoptosis | 1 | 2003 | 9507 | 0.000 |
Why?
|
| Time Factors | 1 | 2009 | 40116 | 0.000 |
Why?
|
| Chromosomes, Human, 16-18 | 1 | 1986 | 32 | 0.000 |
Why?
|
| Immunoglobulin Variable Region | 1 | 1988 | 419 | 0.000 |
Why?
|
| Palatine Tonsil | 1 | 1987 | 193 | 0.000 |
Why?
|
| Neoplastic Stem Cells | 1 | 1994 | 1351 | 0.000 |
Why?
|
| HLA-DQ Antigens | 1 | 1986 | 190 | 0.000 |
Why?
|
| Wounds and Injuries | 1 | 1999 | 2513 | 0.000 |
Why?
|
| Cricetulus | 1 | 1988 | 810 | 0.000 |
Why?
|
| Immunoglobulin Constant Regions | 1 | 1985 | 58 | 0.000 |
Why?
|
| Neoplasm Transplantation | 1 | 1989 | 2010 | 0.000 |
Why?
|
| Disease Progression | 1 | 2002 | 13632 | 0.000 |
Why?
|
| Cross-Sectional Studies | 1 | 2006 | 26294 | 0.000 |
Why?
|
| Molecular Weight | 1 | 1987 | 2168 | 0.000 |
Why?
|
| Genes, MHC Class II | 1 | 1985 | 433 | 0.000 |
Why?
|
| Hematopoiesis | 1 | 1993 | 2060 | 0.000 |
Why?
|
| DNA, Recombinant | 1 | 1984 | 455 | 0.000 |
Why?
|
| Antigen-Presenting Cells | 1 | 1987 | 960 | 0.000 |
Why?
|
| Immunoglobulin alpha-Chains | 1 | 1982 | 8 | 0.000 |
Why?
|
| Immunoglobulin E | 1 | 1989 | 1495 | 0.000 |
Why?
|
| Immunoglobulin mu-Chains | 1 | 1982 | 62 | 0.000 |
Why?
|
| Bone Neoplasms | 1 | 1995 | 2561 | 0.000 |
Why?
|
| Smoking | 1 | 1999 | 9076 | 0.000 |
Why?
|
| Polyploidy | 1 | 1981 | 120 | 0.000 |
Why?
|
| Fertilization | 1 | 1981 | 197 | 0.000 |
Why?
|
| Meiosis | 1 | 1981 | 326 | 0.000 |
Why?
|
| Antigens, CD | 1 | 1990 | 4031 | 0.000 |
Why?
|
| Neoplasm Metastasis | 1 | 1989 | 4888 | 0.000 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 1999 | 11872 | 0.000 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 1985 | 1802 | 0.000 |
Why?
|
| Mice, Inbred BALB C | 1 | 1987 | 6217 | 0.000 |
Why?
|
| Algorithms | 1 | 1998 | 14071 | 0.000 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 1986 | 4348 | 0.000 |
Why?
|
| Diagnosis, Differential | 1 | 1988 | 12979 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 1999 | 36562 | 0.000 |
Why?
|